MARGARET HIRES: Open Payments
NPI 1154639482 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 12 payments from 7 companies in 2025. Trend: 2023 $78 · 2024 $267 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $84 |
| Lilly USA, LLC | 2 | $54 |
| SANOFI PASTEUR INC. | 2 | $52 |
| PFIZER INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: MOUNJARO, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, PAXLOVID, Ozempic, AIRSUPRA, SHINGRIX, Wegovy, JARDIANCE.
Industry payments across CA — which companies pay providers there.
